Nutex Health (NUTX) Q3 2026 earnings review
Nutex Health patient visits jump, but revenue per visit drops
Nutex Health brought more patients into its micro-hospitals, but collected less revenue on each visit and spent more on staff. Total revenue fell 19% from a year ago to $218 million against last year's arbitration catch-up payments, while visits at existing hospitals rose 12%. Chief executive Tom Vo pointed to growing patient volumes and strong cash collections, as newly renegotiated vendor terms cut arbitration fees by a third.
| Same-hospital patient visits | +12.4% from a year ago (+6.3% in Q2) |
|---|---|
| Hospital revenue per visit (by our math) | $3,828 below $4,000–$4,200 target band |
| Diluted profit per share | $5.71 -26% from a year ago |
| Full-year hospital openings outlook | Unchanged 1 opened in Q3; 2 planned for Q4 |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because faster patient traffic and lower arbitration fees were offset by a drop in revenue per visit. By our math, average revenue per hospital visit slipped to $3,828, breaking below the $4,000 to $4,200 steady-state range finance chief Jon Bates set last quarter. The bad news: the stated arbitration win rate stepped down from over 85% to over 80%, while payroll and overhead took an extra 11 percentage points of revenue.
The question now is whether lower revenue per visit reflects a routine shift toward less severe patient cases or shrinking federal arbitration payouts. If less severe cases drove the dip, high visit growth and cheaper dispute fees will lift future profit; if insurers are winning lower arbitration rates, revenue per patient will keep sliding. Management's breakdown on the conference call and fourth-quarter collections will tell.
🐂 Bull Case
Patient Visits Grew Faster at Existing Hospitals
"Patient volumes are growing across both existing hospitals and the overall network, while cash collections remain strong," chief executive Tom Vo said. Nutex Health runs 28 small specialty and micro-hospitals across 12 states, and relies on bringing more patients through existing doors while building new sites.
Hospital division visits rose 18.1% from a year ago to 54,622 in the third quarter. At same hospitals — facilities open before the end of 2024 — visits climbed 12.4%, doubling the 6.3% pace from the second quarter and up from 0.6% in the first quarter. That 5.7-percentage-point gap between total and existing hospital growth shows that newly opened sites are also adding traffic.
What to watch: fourth-quarter facility count and same-hospital visit growth. Opening the two planned hospitals by December while keeping existing facility growth in double digits would show demand can offset lower per-visit payments.
New Fee Terms Cut Arbitration Costs by a Third
Nutex Health sends 50% to 60% of its patient bills through the federal Independent Dispute Resolution (IDR) arbitration process to win higher payments from insurers. In June, the company amended its contract with arbitration vendor HaloMD to pay fees only when cash is collected, while federal regulators cut the administrative fee per dispute from $115 to $15.
The third quarter gave the first clean reading on those new terms without the $52.3 million retroactive accounting credit that distorted second-quarter costs. Total arbitration costs dropped 33.7% from a year ago to $27.8 million, and total contract services expense fell 18.8% to $43.7 million. That fell short of the 25% to 30% drop management projected on a constant-volume basis, because patient visits jumped 18.1%.
What to watch: arbitration costs as a share of arbitration revenue on the conference call. A percentage in the high teens or low twenties would confirm the per-claim savings are holding.
Positives this quarter didn't test
Two standing drivers from earlier quarters received no direct data in the third-quarter earnings release.
- In-house hospital construction: capital spending rose to $5.2 million in the third quarter by our math, up from $3.7 million in the first half, but the full quarterly filing will show how much went to company-owned real estate.
- Federal court rulings on arbitration: previous quarters cited court wins forcing insurers to pay arbitration awards, and the conference call will update how the regulatory environment and federal appeals are affecting collections.
🐻 Bear Case
Revenue Per Visit Fell Below Management's Target
Management has framed average hospital revenue per patient visit as stabilizing between $4,000 and $4,200 after the outsized arbitration catch-up payments of 2025 rolled off. Hospital division revenue fell 19.7% from a year ago to $209.1 million, and same-hospital revenue dropped 20.1%, which the company blamed on last year's high comparison base from "additional collection data that supported higher estimates for services rendered in 2024" and the "reconciliation of certain ineligible charts during the fourth quarter of 2025".
However, revenue per visit also fell from the second quarter, which had no 2025 comparison distortion. By our math, hospital revenue per visit dropped to $3,828 in the third quarter, down from $4,040 in the second quarter and $4,173 in the first quarter. At the same time, the release stated Nutex Health prevailed in "over 80%" of arbitration rulings over the last nine months, stepping down from "over 85%" reported in prior quarters.
What to watch: management's explanation on the call for why per-visit revenue broke below $4,000 and why the stated win rate stepped down. A drop in arbitration award sizes or win rates would cut profit per patient.
Higher Staff Pay and Overhead Cut Into Margins
Finance chief Jon Bates highlighted nine-month operating income rising to $280.1 million, but that nine-month figure includes the second quarter's one-time $52.3 million contract-services accounting credit. In the third quarter alone, operating margin fell 13.2 percentage points from a year ago to 35.4%, and gross margin dropped 11.2 percentage points to 46.7%.
- Payroll (hospital staff pay and benefits): rose 24.7% from a year ago to $48.4 million, climbing 7.8 percentage points of revenue to 22.2%.
- General and administrative expenses (corporate overhead): rose 50.8% to $17.0 million, up 3.6 percentage points of revenue to 7.8%.
- EBITDA excluding one-offs attributable to Nutex Health: fell 35.2% from a year ago to $63.9 million.
Staffing costs are growing faster than the 18.1% rise in patient visits, squeezing hospital profit at the same time per-visit revenue is shrinking.
What to watch: fourth-quarter payroll per visit as two new hospitals open. Rising labor costs above visit growth will keep pressure on operating margins.
Uncollected Bills and Insider Partnerships Take Cash
Nutex Health books revenue based on estimated arbitration collections of over 80%, and consolidates physician groups and real estate entities partly owned by insiders, including the chief executive. Both practices carry ongoing risks for shareholders.
Accounts receivable — billed revenue waiting to be collected in cash — rose another $4.4 million from the second quarter to $356.1 million, up $36.6 million since December even though nine-month revenue fell 10.9%. Meanwhile, noncontrolling interests (the outside and insider partners in those consolidated entities) took $17.1 million, or 29.8% of total third-quarter net income by our math, and received $25.1 million in third-quarter cash distributions.
What to watch: any fourth-quarter revenue adjustment for ineligible arbitration claims. Last year, a fourth-quarter review wiped out $55 million of previously booked revenue from the receivables balance.
💲 Other KPIs
Operating cash flow jumped from $34.2 million in the second quarter to $78.3 million in the third, though down from $99.5 million a year ago when arbitration catch-up collections peaked. That cash generation lifted total cash and equivalents to $249.9 million against just $34.2 million of long-term debt.
Sales at the population health management division — which runs physician networks that coordinate primary care — rose 12.6% from a year ago, though they dipped 4.3% from the second quarter's $8.9 million. The unit remains under 4% of company revenue ahead of planned Texas network launches next year.
Share count edged up by 13,719 shares from June and sits 0.7% below a year ago by our math. Nine-month cash spent on stock buybacks and retirements stayed at $50.7 million, unchanged from the six-month mark, showing the healthcare operator paused repurchases during the third quarter.
🔮 Guidance
Unchanged. Finance chief Jon Bates said the group expects to open two new hospitals in the fourth quarter. Because the hospital count already rose from 27 in June to 28 in the third quarter, opening two more in the fourth quarter completes the full-year plan of three new facilities on schedule.
❓ Key Questions
Why did revenue per visit drop below $4,000?
By our math, hospital revenue per visit fell to $3,828 from $4,040 in the second quarter, below the $4,000 to $4,200 steady-state band management gave last quarter. Investors need to know whether lower patient severity or smaller arbitration awards drove the drop.
Why did the arbitration win rate step down?
The release says Nutex Health won "over 80%" of arbitration rulings over the last nine months, down from "over 85%" in earlier releases. A five-point drop in win rates directly lowers revenue on the 50% to 60% of visits sent to arbitration.
Why did Nutex Health pause stock buybacks in Q3?
Cash spent on share repurchases stayed at $50.7 million for the nine-month period, meaning zero spent in the third quarter despite $19.8 million remaining on the March authorization and cash rising to $249.9 million.
How old are the $356 million in uncollected bills?
Accounts receivable have climbed $36.6 million this year while revenue shrank. Because awards are calculated through March 2026 in the release disclosure, investors need the collection rate and aging on claims billed after March.